Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin II-forming enzymes

European Journal of Pharmacology

Volumn 411, Issue 3, 2001, Pages 301-304

  Takai, Shinji ^a   Jin, Denan ^a   Nishimoto, Masayoshi ^a   Sakaguchi, Masato ^a   Kirimura, Kazuyoshi ^a   Yuda, Atsushi ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Grafting; Phosphodiesterase; Stenosis

Indexed keywords

ANGIOTENSIN; CILOSTAZOL;

ANIMAL TISSUE; ARTICLE; DOG; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION INHIBITION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE; VEIN GRAFT;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; CHYMASES; DOGS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDYL-DIPEPTIDASE A; SERINE ENDOPEPTIDASES; TETRAZOLES; VASODILATOR AGENTS;

EID: 0035847142     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00864-5     Document Type: Article

References (19)

1. Angiotensin II generation by mast cell alpha- and beta-chymases
2. Angiotensin II-forming activity in a reconstructed ancestral chymase
3. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon
4. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
5. Vein graft disease: The clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries
6. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study
7. Role of chymase on vascular proliferation
8. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury
9. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
10. Use of cilostazol, a novel antiplatelet agent, in a post-Palmaz-Schatz stenting regimen
11. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells
12. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury
13. Cilazapril inhibits wall thickening of vein bypass graft in the rat
14. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis
15. Chymase-dependent angiotensin II formation in human vascular tissue
16. Inhibition of chymase reduces vascular proliferation in dog grafted veins
17. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle
18. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty
19. Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins